Publications by authors named "M Manavi"

Background: Epilepsy, a neurological disorder characterized by recurrent seizures, presents considerable difficulties in treatment, particularly when dealing with drug-resistant cases. Dapsone, recognized for its anti-inflammatory properties, holds promise as a potential therapeutic option. However, its effectiveness in epilepsy requires further investigation.

View Article and Find Full Text PDF

Introduction: Epilepsy remains a challenge, with one-third of patients experiencing refractory seizures despite current anti-seizure medications. The nitrergic system, which involves nitric oxide (NO) and NO synthase (NOS) enzymes, plays a complex role in seizure pathophysiology. Pentoxifylline (PTPh), an FDA-approved phosphodiesterase inhibitor, has anticonvulsant effects; however, its relationship with the pathway is unclear.

View Article and Find Full Text PDF

Onchocerciasis, commonly known as river blindness, is a neglected tropical disease caused by the parasite Onchocerca volvulus. It can lead to blindness and visual impairment. Studies have also demonstrated a link between onchocerciasis and epilepsy, with there being a correlation between onchocerciasis endemicity and epilepsy prevalence.

View Article and Find Full Text PDF
Article Synopsis
  • Inhibition of COX and LOX enzymes may help with memory formation and prevent neurodegeneration by reducing neuroinflammation and balancing mitochondrial function.
  • The study investigated the effects of licofelone, a dual COX and LOX inhibitor, on memory and brain health in mice using specific tests after inducing memory loss with scopolamine.
  • Results showed that a high dose of licofelone improved memory immediately after administration, while a lower chronic dose enhanced neural regeneration and reduced cell death, suggesting its potential for preventing memory issues in future clinical research.
View Article and Find Full Text PDF

Spinal cord injury (SCI) leaves a temporary or enduring motor, sensory, and autonomic function loss, significantly impacting the patient's quality of life. Given their biocompatibility, bioactivity, and tunable attributes, three-dimensional scaffolds frequently employ carbohydrates to facilitate spinal cord regeneration. These scaffolds have also been engineered to be novel local delivery platforms that present distinct advantages in the targeted transportation of drug candidates to the damaged spinal cord, ensuring the right dosage and duration of administration.

View Article and Find Full Text PDF